Lab
Waxali INC
Waxali INC was paid $1.60M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 12% of everything it billed.
33Billing provider infoWAXALI INC
NARANJITO, PR 00719
NARANJITO, PR 00719
33aNPI1801994900assigned 09/20/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.60M
24GClaims133,911
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#65 of 777
Median peer was paid$278K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,749 | $204K | |
| 2019 | 16,457 | $160K | |
| 2020 | 16,161 | $184K | |
| 2021 | 21,288 | $330K | |
| 2022 | 17,733 | $278K | |
| 2023 | 19,142 | $218K | |
| 2024incomplete | 20,381 | $228K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 12,278 | 11,815 | $198K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 4,195 | 3,855 | $171K |
| 80061 | Lipid panel | 9.8% | 11,821 | 11,359 | $158K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.1% | 19,738 | 18,362 | $146K |
| 80053 | Comprehensive metabolic panel | 8.2% | 12,983 | 12,383 | $132K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.2% | 4,826 | 4,389 | $116K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.6% | 3,129 | 2,997 | $90K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.3% | 5,522 | 5,311 | $54K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 1,071 | 1,006 | $53K |
| 84153 | 2.4% | 2,151 | 2,065 | $39K | |
| 81000 | 2.2% | 10,628 | 10,110 | $36K | |
| 82274 | 2.0% | 2,106 | 2,041 | $32K |
56 more codes
| 86703 | 1.8% | 2,347 | $29K | |
| 86328 | 1.8% | 1,546 | $29K | |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 3,954 | $26K |
| 84439 | 1.5% | 2,660 | $24K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 615 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 2,617 | $21K |
| 87088 | 1.3% | 2,465 | $20K | |
| 80074 | 1.2% | 401 | $19K | |
| 86738 | 1.1% | 1,344 | $18K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 2,209 | $18K |
| 82043 | 1.1% | 3,120 | $17K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.0% | 442 | $16K |
| 82607 | 1.0% | 1,064 | $16K | |
| 81001 | <1% | 4,364 | $11K | |
| 84436 | <1% | 1,632 | $10K | |
| 87400 | <1% | 385 | $9K | |
| 86592 | <1% | 1,469 | $6K | |
| 87276 | <1% | 501 | $6K | |
| 87275 | <1% | 500 | $5K | |
| 85651 | <1% | 1,518 | $5K | |
| 84479 | <1% | 843 | $5K | |
| 82570 | <1% | 806 | $4K | |
| 80050 | General health panel | <1% | 388 | $4K |
| 85730 | <1% | 632 | $4K | |
| 87184 | <1% | 560 | $3K | |
| 82947 | <1% | 818 | $3K | |
| 85610 | <1% | 727 | $3K | |
| 86038 | <1% | 218 | $3K | |
| 82950 | <1% | 519 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 45 | $2K |
| 82270 | <1% | 463 | $2K | |
| 86803 | <1% | 106 | $2K | |
| 82728 | <1% | 95 | $1K | |
| 82951 | <1% | 92 | $1K | |
| 87177 | <1% | 163 | $1K | |
| 86140 | <1% | 207 | $1K | |
| 83540 | <1% | 150 | $991.35 | |
| 82042 | <1% | 149 | $806.00 | |
| 84460 | <1% | 173 | $777.17 | |
| 84550 | <1% | 171 | $758.30 | |
| 82746 | <1% | 36 | $550.12 | |
| 84450 | <1% | 111 | $478.41 | |
| 84481 | <1% | 30 | $472.45 | |
| 80069 | <1% | 52 | $430.88 | |
| 83655 | <1% | 33 | $401.22 | |
| 86376 | <1% | 27 | $375.53 | |
| 83001 | <1% | 17 | $299.14 | |
| 83002 | <1% | 16 | $274.90 | |
| 86800 | <1% | 17 | $270.08 | |
| 83550 | <1% | 28 | $247.47 | |
| 82785 | <1% | 12 | $193.62 | |
| 84478 | <1% | 43 | $188.06 | |
| 82952 | <1% | 34 | $166.49 | |
| 82465 | <1% | 47 | $159.64 | |
| 82272 | <1% | 33 | $128.41 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 449 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLLAZO ROSADO, JOSE (PRESIDENT OWNER)
Parent organizationWAXALI INC
| Provider | Location | Paid |
|---|---|---|
| Waxali INC | Barranquitas, PR | $1.03M |
| Waxali INC | Naranjito, PR | $773K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.